Related Experiment Videos
Quantitative motor assessment in FALS mice: a longitudinal study
P Barnéoud1, J Lolivier, D J Sanger
1Central Nervous System Research Department, Synthelabo Recherche, Rueil-Malmaison, France.
Neuroreport
|October 6, 1997
Summary
This study evaluated motor function deficits in a transgenic mouse model of familial amyotrophic lateral sclerosis (ALS). Findings reveal early impairments in muscle strength and coordination, supporting its use for ALS drug development.
Area of Science:
- Neuroscience
- Genetics
- Animal Models of Disease
Background:
- Familial amyotrophic lateral sclerosis (FALS) is a progressive neurodegenerative disease.
- Transgenic mouse models are crucial for understanding ALS pathogenesis and testing therapeutics.
- The G1H transgenic mouse line overexpresses a familial SOD1 mutation (Gly-93-->Ala).
Purpose of the Study:
- To characterize the early motor function deficits in the G1H transgenic mouse model.
- To determine the order of appearance of these motor impairments.
- To validate the G1H mouse as a model for familial ALS.
Main Methods:
- Evaluation of motor function using various behavioral tasks.
- Assessment of muscle strength, coordination, and spontaneous activity.
- Longitudinal observation of motor performance from 8 to 15 weeks of age.
Main Results:
- Earliest motor deficits detected in muscle strength and coordination at 8 weeks of age.
- Biphasic development of motor impairments observed.
- Spontaneous activity remained unimpaired until 15 weeks of age.
Conclusions:
- The G1H mouse model exhibits early motor deficits mirroring human ALS.
- These findings reinforce the G1H mouse's validity as an animal model for FALS.
- This model facilitates the investigation of novel therapeutic strategies for ALS.